Peptides8 min read
DSIP and deep sleep: what an EEG can actually establish
What scalp EEG, deep-sleep staging and a small anaesthesia experiment can tell us about DSIP and restorative sleep.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides8 min read
Why MOTS-c studies disagree about blood levels
Different obesity and aging studies report different MOTS-c patterns. Population, tissue, timing, units and assay methods explain why comparisons need care.
Read article
Peptides9 min read
KPV in 2026: what human research still needs to answer
What KPV's intestinal and skin research shows, how the K(D)PT trial differs, and which patient questions remain after the 2026 discussion.
Read article
Peptides8 min read
What TB-500 half-life claims need to show
Rat metabolites, horse detection studies, and human thymosin beta-4 trials answer different questions. None supplies a dosing timetable for the TB-500 fragment.
Read article
Peptides8 min read
Humanin, HNG and other analogues: why the exact molecule matters
Native humanin, HNG, HNGF6A and colivelin differ in structure and experimental behavior. Understand why laboratory potency is not a clinical conversion ratio.
Read article
Peptides8 min read
GHRP-2 and cortisol: why measuring more than growth hormone matters
Human experiments show that GHRP-2 can affect ACTH, cortisol and prolactin as well as growth hormone. Here is what those findings mean—and what remains unknown.
Read article
Peptides9 min read
Why IGF-1 LR3 cell studies cannot establish a bodybuilding protocol
Cell differentiation, tissue weight and strength are different outcomes. Primary LR3 studies show why the distinctions matter.
Read article
Peptides9 min read
Does a retatrutide weight-loss curve predict your result?
What retatrutide's trial averages, responder thresholds and weight curves can tell you—and why they cannot forecast your personal result.
Read article
Peptides9 min read
Petrelintide's long-acting design: beyond convenience
A roughly ten-day half-life helps explain weekly development, but absorption, accumulation, tolerability and formulation stability answer different questions.
Read article
Peptides8 min read
Zenagamtide: one molecule versus a drug combination
A single peptide can activate more than one receptor system. That makes zenagamtide scientifically distinct from giving cagrilintide and semaglutide together.
Read article
Peptides9 min read
What an LH rise after gonadorelin can and cannot prove
An LH rise after gonadorelin is a pituitary response, not a complete fertility result. Timing, baseline values, cycle phase and treatment context shape its meaning.
Read article
Peptides8 min read
Thymosin beta-4 versus TB-500: why the actual molecule matters
Full-length thymosin beta-4 and the TB-500 fragment share a sequence region, but their names, laboratory findings and human trials should not be merged.
Read article253–264 of 323 articles